Search Results

You are looking at 1 - 10 of 1,691 items for :

  • Refine by Access: All Content x
Clear All

foals may have reduced athletic performance. 1 , 4 To date, a vaccine to prevent RE pneumonia has not been licensed in the United States (US). A vaccine remains elusive largely because foals appear to be infected very soon after birth 5 when they

Open access
in American Journal of Veterinary Research
in Journal of the American Veterinary Medical Association

infection is generally used prophylactically to reduce morbidity and mortality rates among swine. 2 Development of a CSFV vaccine has included assessment of early inactivated-virus vaccines, attenuated-virus vaccines, and genetically engineered vaccines. 3

Full access
in American Journal of Veterinary Research

remains an elusive goal. Vaccination is an important adjunct to improvements in management, nutrition, and biosecurity. For some animals, such as young calves with circulating maternal antibodies, vaccine administration by the IN route may result in a

Full access
in Journal of the American Veterinary Medical Association

V accination of animals is a critical preventive strategy against potentially fatal or debilitating infectious diseases in animals and is an important tool to protect the public from zoonotic diseases. Vaccines provide protection against these

Open access
in American Journal of Veterinary Research

for immunoprophylactic interventions early in life when maternal immunity may affect successful immunization. 1–4 Several commercial BRSV vaccines, including modified-live virus and inactivated single fraction and combination products, 4,6 are

Full access
in Journal of the American Veterinary Medical Association

United States are at risk of contracting the European strain as well. Results from experimental studies and field observations indicate that the viruses from the 2 lineages are sufficiently different to adversely affect vaccine efficacy, 9 and as a

Full access
in American Journal of Veterinary Research

potential and the effects on show animals are additional negative effects of this disease. The first vaccine for contagious ecthyma was developed at the Texas Agricultural Experiment Station (presently known as Texas AgriLife Research) at Sonora, Tex, in

Full access
in American Journal of Veterinary Research

An rCP-FeLV vaccine that incorporates the env and gag genes of FeLV has been licensed by the USDA for use in cats. 1,2 This vaccine has been shown to induce protection against oronasal challenge with FeLV that is equivalent to the protection

Full access
in Journal of the American Veterinary Medical Association